Moderna Inc.
View real-time stock prices and stock quotes for a full financial overview.

Range dropdown markets
Sectors
Nasdaq
Volume: 2.69M 65-Day Average: 4.19M
64% vs Average 146.90 Days Range 153.76, 115.03 52-Week Range 217.25
Partner Center
Your Watchlists
Recent Viewed Tickers
Key Data
% of Float Shorted 4.677%
Average Volume 4.19M
Performance
5 Days
-0.40%
1 Month
7.30%
3 Months
-24.94%
YTD
-16.81%
1 Year
-9.94%
Analyst Ratings
Buy
Ratings: 21 Ratings
MarketWatch Dow Jones
Moderna Inc. stock rises Thursday, still underperforms market
Mar. ET by MarketWatch Automation
Generation Bio, Moderna announce collaboration
Mar. ET by Jaimy Le
Generation Bio shares rise 19% thanks to Moderna Strategic Collaboration
Mar. ET
Generation Bio and Moderna Join Collaboration to Accelerate Nonviral Genetic-Medicines Pipeline
Mar. ET
Moderna Inc. stock performs poorly Wednesday compared to its competitors
Mar. ET by MarketWatch Automation
Moderna CEO defends Congress price hike for COVID vaccine
Mar. ET by Jaimy Le
Senate grills Biotech and Pharma Moderna CEOs on Price of Covid-19 Vaccine
Mar. ET by Barron's
China allows first homegrown mRNA COVID vaccine to be used in an emergency: WSJ
Mar. ET by Ciara Linnane
Markets: The Bank Turmoil isn't Over. The Fed Looking Forward: What it Means.
Mar. ET
Moderna Inc. stock falls Tuesday, underperforms market
Mar. ET by MarketWatch Automation
Moderna Inc. stock rises Monday, outperforms market
Mar. ET by MarketWatch Automation
Moderna Inc. stock performs poorly Friday compared to its competitors
Mar. ET by MarketWatch Automation
How a nasal vaccination could lower the risk of COVID infection -- and how it can be modified
Mar. ET by Jaimy Le
Moderna Inc. stock rises Thursday, still underperforms market
Mar. 16, 2023 at 4 :31 p.m. ET by MarketWatch Automation
Moderna is boosted by expansion plans. However, SVB fallout continues pressure on banks and financials
Mar. ET by Ciara Linnane
Moderna will hire 2,000 people and open new offices on the West Coast.
Mar. ET by Claudia Assis
Markets Retail Earnings Show Uncertain Outlook. The Fed needs consumers to cut back.
Mar. ET
Panel of FDA Panels from Biotech and Pharma Says Pfizer's RSV Vaccine is Safe and Effective
February 28, 2023, at 4:33 p.m. ET by Barron's
Biotech and Pharma Novavax say there is'substantial doubt' about its ability to continue operating this year
February 28, 2023, 4:02 p.m. ET by Barron's
Moderna Inc.
Moderna, Inc. is involved in the development and commercialization of transformative medicines that are based on messenger-ribonucleic acids (mRNA). Its product portfolio includes: prophylactic vaccinations, cancer vaccines and intratumoral immuno-oncology. Noubar B. Afeyan and Robert S. Langer Jr. founded the company. Derrick J. Rose and Kenneth R. Chien founded the company in Cambridge, MA in 2010.
Competitors
CureVac N.V. $1.44B -0.62%